Assembled from the company's filings and exchange data as of today. Download PDF renders this page on the server; the narrative sections arrive with the Nexa composer.
Dossier · VIKAS LIFECARE LIMITED · 9 October 2026Page 1 of 3
Company Dossier
MarketPing Research · factual · no rating expressed
VIKAS LIFECARE LIMITED
NSE: VIKASLIFE · BSE: 542655
NSE: VIKASLIFE · BSE: 542655
Services › Services › Commercial Services & Supplies › Trading & Distributors
VIKAS LIFECARE LIMITED
StateQ3 FY26 filed
Last close · 9 Oct 2026₹1.20
Market cap₹0.2k cr
TTM P/E · P/B · EV/EBITDA— · 0.40 · —
VIKAS LIFECARE LIMITED is a Commercial Services & Supplies company listed on NSE. The annual-report business brief for this company has not been generated yet; the numbers below are as filed.
What a broker report prints here — the analyst's thesis. This dossier prints the filed record instead; the narrative read of the latest results, the guidance ledger and the earnings-call summary are the composer's sections (INSTITUTIONAL-PLAN.md M3) and are not yet produced.
Exhibit 1: Financial summary, FY22–FY25 (all audited; no estimate years)
| ₹ crore · consolidated | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Revenue | 301 | 476 | 446 | 480 |
| EBITDA (ex other income) | (1) | 12 | (3) | (28) |
| margin % | (0.3) | 2.5 | (0.6) | (5.7) |
| Owners' profit | 29 | (15) | 14 | 0 |
| EPS, as reported (₹) | 0.25 | (0.11) | 0.09 | (0.04) |
| ROE % · ROCE % | 14.5 · 19.1 | (4.6) · (5.5) | 2.8 · 4.0 | (2.0) · (1.4) |
| Debt / equity (x) | 0.12 | 0.09 | 0.07 | 0.14 |
| Cash from operations | (15) | (110) | (42) | (222) |
| Capex | (2) | (18) | (16) | 0 |
Source: SEBI results XBRL as filed with BSE/NSE; EBITDA excludes other income.
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in
Dossier · VIKAS LIFECARE LIMITED · 9 October 2026Page 2 of 3
Exhibit 2: Quarterly performance, last 8 quarters
| ₹ crore | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 132 | 92 | 135 | 118 | 135 | 92 | 141 | 97 |
| Profit before tax | (1) | 0 | (1) | (7) | (5) | (3) | (120) | (33) |
| Net profit | (2) | (3) | 2 | (7) | (3) | (3) | (119) | (29) |
| EPS (₹) | (0.03) | 0.00 | 0.03 | (0.04) | (0.02) | (0.02) | (0.64) | (0.16) |
Source: quarterly results as filed; the balance sheet is filed half-yearly and is not repeated here.
Exhibit 3: Segment revenue, FY25
| Segment | Revenue, ₹ crore | Share % |
|---|---|---|
| Trading & Manufacturing Division- Polymers | 4 | 0.9 |
| Trading & Manufacturing Division - Agro | 96 | 20.1 |
| Trading & manufacturing Division- Infrastructure | 35 | 7.3 |
| Trading and manufacturig Division-Agro | 214 | 44.6 |
| Trading and manufacturig Division-Polymers | 10 | 2.1 |
| Trading and manufacturing Divivsion-Infrastructure | 26 | 5.4 |
| Trading division- gas meter | 1 | 0.1 |
| Trading Division-Gas Meter | 3 | 0.6 |
| Trading and manufacturing Division-Agro | 69 | 14.3 |
| Trading and manufacturing Division-Infrastructure | 20 | 4.1 |
| Trading and manufacturing Division-Polymers | 3 | 0.7 |
| Total, before eliminations | 480 | 100.0 |
Source: the filed segment block, four quarters summed.
Exhibit 4: Peers — basic industry group, by market cap
| Company | M.cap ₹ cr | P/E | P/B | EV/EBITDA | ROE % | ROCE % | Rev CAGR 5y % | EBITDA m. % |
|---|---|---|---|---|---|---|---|---|
| REDINGTON LIMITED | 30,351 | 17.8 | 2.91 | 14.1 | 12.3 | 15.7 | 15.9 | 2.2 |
| MMTC LIMITED | 8,166 | 18.3 | 3.85 | 17.4 | 18.3 | 21.6 | (83.7) | 18426.5 |
| MSTC LIMITED | 4,696 | 20.0 | 5.20 | 13.9 | 24.2 | 31.8 | (13.9) | 86.5 |
| CREATIVE NEWTECH LIMITED | 1,593 | 24.5 | 4.11 | 18.4 | 18.1 | 21.0 | — | 5.2 |
| Pervasive Commodities Limited | 1,178 | — | 13.10 | — | (0.0) | (0.0) | — | 45.0 |
| The Yamuna Syndicate Ltd | 755 | 8.3 | 0.59 | 190.1 | 4.0 | 0.3 | 4.8 | 6.2 |
| SHIV AUM STEELS LIMITED | 748 | 65.8 | 6.19 | 47.7 | 6.0 | 6.9 | — | 4.9 |
| SHANKARA BUILDPRO LIMITED | 609 | 4.6 | 1.12 | 2.7 | 23.4 | 31.8 | — | 3.3 |
Source: exchange data and filed statements via the screener; multiples at current prices.
Exhibit 5: Where the company sits in its group
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| P/B | 0.4 | 1.0 | 34 of 150 | 77% |
| ROCE | 0.9 | 2.1 | 110 of 177 | 38% |
| ROE | 1.1 | 2.3 | 91 of 158 | 43% |
| Debt / Equity | 0.2 | 0.1 | 97 of 154 | 37% |
| EBITDA margin | (30.6) | 4.5 | 121 of 137 | 12% |
| Revenue growth | (17.7) | (8.6) | 74 of 135 | 46% |
| Profit growth | (327.0) | 0.6 | 139 of 157 | 12% |
| Market cap | 221 | 22 | 19 of 180 | 90% |
Source: MarketPing peer ranks; a rank is a measurement, not a view.
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in
Dossier · VIKAS LIFECARE LIMITED · 9 October 2026Page 3 of 3
Exhibit 6: Filings of the last 90 days, with the measured price reaction
| Date · filing | Category | Importance | 1-day % | 5-day % |
|---|---|---|---|---|
| 26 Sept 2026 · Trading window closure ahead of Q2 FY26-27 results | compliance | minimal | — | — |
| 17 Sept 2026 · AGM for FY2026 extended by 2 months and 28 days | board shareholder meetings | medium | — | — |
| 8 Sept 2026 · Vikas Lifecare seeks extension for FY26 AGM from Registrar of Companies | general | low | — | — |
| 10 Aug 2026 · FY26 results with qualified opinion; ED property attachment under PMLA disclosed | regulatory legal | high | — | — |
| 31 Jul 2026 · NSE seeks clarification from Vikas Lifecare on Sept quarter results | regulatory legal | medium | — | — |
| 17 Jul 2026 · Exchange seeks clarification from Vikas Lifecare on Q1 FY26 results | regulatory legal | high | — | — |
| 15 Jul 2026 · Promoter Vikas Garg taken into ED custody under PMLA | compliance | minimal | — | — |
| 11 Jul 2026 · Routine compliance certificate on share dematerialization for Q1 FY27 | compliance | minimal | — | — |
| 9 Jul 2026 · Vikas Lifecare FY26 results; auditor gives qualified opinion | results | high | — | — |
| 9 Jul 2026 · Vikas Lifecare FY26 profit of Rs 86 cr but auditor flags major risks | board shareholder meetings | medium | — | — |
Source: exchange announcements; reaction = close-to-close from the filing's session.
How to read this document
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) | A state: the latest filed quarter and the measured reactions | an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
Sources, method and disclosures
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in